Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

BACKGROUND: In studying the therapeutic evidence of innovative drug treatments, increasing attention is being devoted to differentiating between results that indicate no significant differences among the treatments under examination (“no proof of difference”) and results that demonstrate the therape...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2014
Aiheet:
Brief Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4065299/
https://ncbi.nlm.nih.gov/pubmed/24793219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-014-0066-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia